The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those
patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will
be accomplished by development of a database of these patients, all of whom will have biopsy
documented NASH. A placebo controlled trial will then examine the effect of
S-adenosylmethionine over time on clinical outcome in these patients. It is expected that
this agent will slow or halt the progression of this disease.
- Men with biopsy proven non-alcoholic steatohepatitis from the liver disease clinic or
referred from other physicians from the VAMC-Louisville.